MedTrace Logo

Tools for Anxiety and Depression Screening in Epilepsy

NCT05864612 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 880

Last updated 2025-10-30

Study results available
· View outcomes & findings →

Summary

A randomized trial to compare patient-completion success of REDCap and Electronic Health Record (EHR)-based anxiety \& depression instrument delivery methods. Study hypothesis is that the screening completion proportion will vary across the 4 modalities tested.

Conditions

Interventions

BEHAVIORAL

Screening Questionnaires

Standard care screening questionnaires on anxiety and depression

Sponsors & Collaborators

  • National Center for Advancing Translational Sciences (NCATS)

    collaborator NIH

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Heidi M. Munger Clary, MD, MPH · Wake Forest University Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-20
Primary Completion
2024-09-03
Completion
2024-09-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05864612 on ClinicalTrials.gov